Navigation Links
Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Date:9/16/2008

roven effective in all three key measures of treatment effectiveness: MRI lesion area and activity*, relapse rates and disability progression. The safety profile of Rebif(R) is supported by a robust, ongoing clinical development and post-marketing program and a 10-year record of use by MS patients.

The REFLEX trial is being conducted with the new formulation of Rebif(R). The new formulation of Rebif(R) was approved in the European Union in August 2007 and in Canada in September 2007 and is now marketed in all EU countries and in Canada. The new formulation of Rebif(R) is not available in the United States.

* The exact correlation between MRI findings and the current or future clinical status of patients, including disability progression, is unknown.

About Rebif(R)

Rebif(R) (interferon beta-1a) is a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS) and is similar to the interferon beta protein produced by the human body. The efficacy of Rebif(R) in chronic progressive MS has not been established. Interferons are thought to help modulate the body's immune system and reduce inflammation. The exact mechanism is unknown.

Rebif(R), which was approved in Europe in 1998 and in the US in 2002, is registered in more than 80 countries worldwide. Rebif(R) has been proven to delay the progression of disability, reduce the frequency of relapses and reduce MRI lesion activity and area*. Rebif(R) is available in a 22 micrograms and 44 micrograms ready-to-use pre-filled syringe and a titration pack (8.8 micrograms).

Rebif(R) should be used with caution in patients with a history of depression, liver disease and seizures. Most commonly reported side effects are flu-like symptoms, injection site disorders, elevation of liver enzymes and blood cell abnormalities. Patients, especially those with depression, seizure disorders, or liver problems, should discuss treatment with Rebif(R) with their doctors. For more info
'/>"/>

SOURCE Merck Serono International S A
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
2. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
3. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
4. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
5. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
9. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
10. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
11. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Today, Avantium announced the,appointment of Gunnar ... pharmaceutical,business. Gunnar Staaf previously worked at Serentis ... Company, in a range of commercial and ... in Avantium,s plan to,spin-out its pharmaceutical business. ... company based on its offering of proprietary,crystallization ...
(Date:12/16/2009)... Dec. 16 GlaxoSmithKline plc [GSK] (NYSE: ... announced an exclusive licensing agreement in the United ... of NB-001, a novel, patented compound representing the ... Developed by NanoBio, NB-001 provides significant antimicrobial activity ... herpes labialis . ,, Cold sores are ...
(Date:12/16/2009)... AARP Illinois Disappointed By Senate Vote Against Lower ... The U.S. Senate on Tuesday night ... Affordable Care Act that would help make prescription ... and legal importation of lower priced drugs from ... and sponsored by Senators Dorgan, Snowe, McCain, Grassley ...
Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2AARP Illinois Key Vote News Alert 2Clinical Studies Validate Cancer Gene Delivery Platform 3A Landmark Publication Confirms Rexin G Effectively Targets Metastatic Cancers and Improves P 49657 1Clinical Studies Validate Cancer Gene Delivery Platform 3A Landmark Publication Confirms Rexin G Effectively Targets Metastatic Cancers and Improves P 49657 2Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 1Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 2Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 3Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 4PhRMA Statement on AARP White House Press Conference 12729 1PhRMA Statement on AARP White House Press Conference 12729 2
(Date:12/17/2009)... a revealing portrait of the nearly one-in-three American adults who serve ... ... December 17, 2009 -- The National Alliance on Mental Illness (NAMI) ... which offers a revealing portrait of the nearly one-in-three American adults ... based on interviews with 1,480 caregivers chosen at random and offers ...
(Date:12/17/2009)... over the past three years and what has driven these changes ... ... Morehead, the human capital research firm, will host a webinar titled ... free hour-long webinar will be broadcast on Wednesday, January 27, 2010 ... Morehead’s SVP, Consulting Services and Trevor Byrd, Ph.D., a Morehead Consultant, ...
(Date:12/17/2009)... businesses listed on search engines like Google Local and in front ... presence with SEO Local Registration service offered by New Orleans based ... ... December 17, 2009 -- In order to be competitive locally and ... a listing on a local map section in a major search ...
(Date:12/17/2009)... will provide Baptist with on-going Healthcare Cost/Risk Analysis reports, activity ... health improvements as it translates toward reduced claim costs and ... , ... Jacksonville, FL ... health risk management company specializing in clinical/claims based cost risk ...
(Date:12/17/2009)... marketing techniques, life coaching company puts free i-phone & ... http://itunes.apple.com/us/app/attainment-life-management/id345691804?mt=8 . For the Free download. , ... ... -- Utah based Attainment Life Management & Coaching is ... everything in life simplified into one little hand held ...
Breaking Medicine News(10 mins):Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review" 2Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2
... African ministers have formulated a plan to combat the ... continent. //The plan was agreed to during the one-day ... of ministers in charge of agriculture, health, livestock, environment ... of the meeting said that the ministers "examined and ...
... the last detail. But the mobile phone messages proved their ... in the crime. ,The murder last Sunday of 30-year-old ... Kerala's Idukki district had been scripted by his wife, 24-year-old ... their honeymoon. ,The couple, who are from Chennai, ...
... Recent research has revelaed that it is better to ... it to flow into the sewer, from an environmental// ... University of Technology researcher Jac Wilsenach, who on Monday ... this research subject. ,Wilsenach estimates that substantial ...
... in the age of baby boomers. This has brought ... the scenario. Patients are// now seeking new therapy and ... ED, known as PDE-5 inhibitors, have revolutionized treatment for ... series of studies, Jack Mydlo, MD, professor and chair ...
... reduction in the bone mass and density increasing the susceptibility ... approximately 10 million Americans above the age of ... (HSPH), scientists have discovered that the removal of a protein, ... their overall bone mass. The results may have profound implications ...
... Toronto's Department of Nutritional Sciences say that the glycemic ... small or large portions are consumed. This should come ... GI was developed 25 years ago at U of ... table has become an important tool for the management ...
Other Medicine News:Health News:Mobile Phone Messages Assists in Unraveling Murder Mystery 2Health News:Urine Purification to Revolutionize Waste Water Management 2Health News:Non Surgical Medication Drugs Prove To Be Effective In Treating ED 2Health News:Research Identifies Osteoporosis Controlling Protein 2Health News:Glycemic Index Works For Diabetes Patients 2
Hydrodissection / Aspiration Cannula, 25 g. Angled with left hook. 10 mm angled shaft with 2.5 mm left hook tip. Overall length 20 mm. 5/box....
Irrigating Capsulorhexis Cystotome. Formed angled tip, 27 g. Overall length 16 mm. 5/box....
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Retrobulbar Needle, 23 g. Atkinson style bevel. Overall length 38 mm. 5/box....
Medicine Products: